Alastair Smith joins DirectorsTalk to discuss the news that in just 4 weeks it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen as part of the collaboration with Cytiva. Alastair reminds us what the partnership entails, explains what this now means and what we can expect from the collaboration and Avacta going forward.